Mohan Pankaj

CIK 00016643862 companiesCRANBURY, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001664386

Recent Transactions

26 trades

Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-12-11+7,554→ 14,987 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Warrant to Purchase Common Stock
2023-10-27+68,750→ 68,750 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-10-27+34,375→ 59,526 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-05-15$0.22/sh+371,600→ 553,331 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-03-15$0.58/sh+60,000→ 181,731 total
Disposition to Issuer
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-01-07−73,561→ 48,170 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2023-01-07+73,561→ 121,731 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2022-12-14+74,205→ 748,606 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2021-12-15+320,135→ 674,401 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2021-06-09$1.55/sh+28,000→ 354,266 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2021-06-09$1.54/sh+4,000→ 326,266 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-07-02+319,866→ 322,266 total
Purchase
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-06-10$4.09/sh+2,400→ 2,400 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-04-01+7,992→ 7,992 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-04-01+930,705→ 930,705 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Common Stock
2020-04-01+1,591,116→ 1,591,116 total
Award
Sonnet BioTherapeutics Holdings, Inc.
Warrant to Purchase Common Stock
2020-04-01+4,263→ 4,263 total
Purchase
Outlook Therapeutics, Inc.$OTLK
Common Stock
2019-01-15$0.68/sh+8,000→ 7,064,553 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2018-11-09$0.61/sh+114,157→ 114,157 total
Award
Outlook Therapeutics, Inc.$OTLK
Stock Option (Right to Buy)
2018-09-21+15,000→ 15,000 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-01-04$1.16/sh−62,569→ 7,056,553 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2018-01-03$1.18/sh−52,108→ 7,119,122 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2017-12-19$1.14/sh−83,608→ 7,171,230 total
Sale
Outlook Therapeutics, Inc.$OTLK
Common Stock
2017-12-18$1.17/sh−20,523→ 7,254,838 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Series A Preferred Stock
2016-05-18−106→ 0 total
Conversion
Outlook Therapeutics, Inc.$OTLK
Common Stock
2016-05-11+17,666→ 39,405 total

Companies

Recent Filings

Address

C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE

CRANBURY, NJ, 08512

View on SEC.gov